Multistrain Probiotics Against Bacterial Vaginosis
Status:
TERMINATED
Trial end date:
2024-06-03
Target enrollment:
Participant gender:
Summary
The primary aim of the study is to clarify whether and to what extent the consumption of the multistrain probiotic OMNi-BiOTiC FLORA plus+ has a positive effect on the vaginal flora and reduces BV. This is determined using the Nugent score and the blackbird criteria.
In one subgroup, the composition of the vaginal microbiome is analysed using 16S rRNA gene sequencing.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Institut AllergoSan Pharma GmbH
Collaborators:
Medical University of Vienna MEDIZINISCHE UNIVERSITAT GRAZ Medizinische Universitt Innsbruck, OE Clinical Trial Center (Koordinierungszentrum fr klinische Studien, KKS)